BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3582245)

  • 1. [Phospholipid composition of blood lipids in breast and uterine cancer].
    Kotrikadze NG; Tsartsidze MA; Dzhishkariani OS; Londaridze AM; Lomsadze BA
    Eksp Onkol; 1987; 9(2):68-70. PubMed ID: 3582245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change in lipid peroxidation, structural status and level of phospholipids in the blood of patients with fibroma and cancer of the uterus].
    Kotrikadze NG; Dzhishkariani OS; Tsartsidze MA; Londaridze AM; Gabuniia GD; Lomsadze BA
    Eksp Onkol; 1989; 11(5):71-3. PubMed ID: 2791960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in plasma phospholipid composition and lipid antioxidant activity of breast tumor patients without and following radiation therapy].
    Kal'nova NIu; Pal'mina NP
    Vopr Med Khim; 1981; 27(4):510-3. PubMed ID: 7306317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proton magnetic resonance study of the changes in blood lipids in malignant and benign neoplasms].
    Katrikadze NG; Tsarpidze MA; Dzhishkariani OS; Sibel'dina LA; Bochorishvili IA
    Biofizika; 1999; 44(4):731-6. PubMed ID: 10544827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1H-NMR of blood lipids in malignant and benign tumors].
    Iushmanov VE; Kotrikadze NG; Pershin AD; Dzhishkariani OS; Tsartsidze MA
    Vopr Onkol; 1989; 35(5):560-4. PubMed ID: 2741425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose erythrocyte transporter in women with breast cancer: changes in lipid composition of erythrocyte membrane.
    Crespí C; Quevedo S; Roca P; Palou A
    IUBMB Life; 1999 Nov; 48(5):531-7. PubMed ID: 10637770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The erythrocyte functional status and phospholipid composition in breast cancer patients].
    Domanskiĭ VIu
    Vopr Onkol; 1992; 38(10):1194-202. PubMed ID: 1343145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of chemotherapy on the total unsaturation and composition of plasma phospholipids and erythrocytes in patients with disseminated breast cancer].
    Korman DB; Potapov SL; Shamaev VI; Pal'mina NP; Burlakova EB
    Izv Akad Nauk SSSR Biol; 1992; (2):206-14. PubMed ID: 1430576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phospholipid concentrations and localization of selected phospholipids in erythrocyte membranes of breast tumor patients].
    Schneider E; Brachmann K; Haude W
    Z Med Lab Diagn; 1990; 31(6):321-6. PubMed ID: 2281713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of hydroxylated phosphocholine lipids in the blood serum of breast cancer patients.
    Hammad LA; Wu G; Saleh MM; Klouckova I; Dobrolecki LE; Hickey RJ; Schnaper L; Novotny MV; Mechref Y
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):863-76. PubMed ID: 19224569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in lipid peroxidation and phospholipid spectrum of blood in patients with lung cancer].
    Khyshiktuev BS; Khyshiktueva NA; Ivanov VN; Darenskaia SD
    Vopr Onkol; 1993; 39(7-12):288-91. PubMed ID: 7825299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy].
    Morimoto K; Koh M
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1517-24. PubMed ID: 15508443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclic adenosine monophosphate content in the lymphocytes of cancer patients].
    Bershteĭn LM; Revskoĭ SIu; Kovaleva IG; Dil'man VM
    Eksp Onkol; 1985; 7(5):53-6. PubMed ID: 2998725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
    Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
    Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma concentrations of non-esterified fatty acids and lipids in high-dose medroxyprogesterone therapy of metastatic breast cancer].
    Hofmann M; Holzer A; Brockerhoff P; Rathgen GH
    Zentralbl Gynakol; 1993; 115(11):495-9. PubMed ID: 8296495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the phospholipid content and the antioxidant activity of erythrocyte lipids in mammary gland tumors and during radiotherapy].
    Kal'nova NIu; Pal'mina NP
    Biokhimiia; 1980 Sep; 45(9):1646-53. PubMed ID: 7248364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood prolactin level of breast and endometrial cancer patients during surgical intervention].
    Pozdniakov VV; Bobrov IuF; Gamaiunova VB; Evtiukhin AI; Frid IA
    Vopr Onkol; 1984; 30(2):9-14. PubMed ID: 6702135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid compositions of inositol and choline phospholipids of breast tumours and normal breast tissue.
    Williams CM; Maunder K
    Eur J Clin Nutr; 1993 Apr; 47(4):260-7. PubMed ID: 8491163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
    Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP
    Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.